Endocrine Abstracts

Background: Very little is written regarding injection site reactions to somatostatin analogues and although very rare we are unprepared in dealing with these reactions. Patients are then met with an uncertain clinical team leading to significant delay in treatment. This poster aims to highlight the potential risks of injection site reactions by sharing an extreme case study. It will also share our attempt to deal with injection site reactions, lesson learnt and recommendation...

Background: The median survival for patients with metastatic neuroendocrine tumours is greater than 5 years. Despite a heavy burden of metastatic disease and an incurable diagnosis many patients continue with a relatively normal lifestyle. Vast amounts of time and money is spent on diagnosing and treating the physical aspects of cancer but little is currently available to help with the psychological wellbeing of our patients. As NET nurses we spend large amounts of our time ta...